Related content

Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate

By Ogungbenro Kayode   Aarons Leon  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 173-185

Springer Publishing Company

Access to resources Recommend Favorite

Mercaptopurine/methotrexate: Hodgkin's disease in children with ALL?: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Bayesian Estimation of Methotrexate Pharmacokinetic Parameters and Area Under the Curve in Children and Young Adults with Localised Osteosarcoma

By Rousseau A.  

Clinical Pharmacokinetics, Vol. 41, Iss. 13, 2002-01 ,pp. : 1095-1104

Adis International

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental Agents

By Ginsberg Gary   Hattis Dale   Russ Abel   Sonawane Babasaheb  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 4, 2004-06 ,pp. : 297-329

Taylor & Francis Ltd

Access to resources Recommend Favorite

The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX) - an update with focus on mechanisms involved in toxicity

By Giverhaug T.   Loennechen T.   Aarbakke J.  

General Pharmacology, Vol. 33, Iss. 4, 1999-10 ,pp. : 341-346

Elsevier

Access to resources Recommend Favorite